Pulmonary Artery Pressure–Guided Heart Failure Management Reduces 30-Day Readmissions

• Published in: Circulation. Heart failure Vol. 9; no. 6
• Main Authors: Adamson, Philip B., Abraham, William T., Stevenson, Lynne Warner, Desai, Akshay S., Lindenfeld, JoAnn, Bourge, Robert C., Bauman, Jordan
• Format: Journal Article
• Language: English
• Published: United States 01.06.2016
• Subjects: Aged; Aged, 80 and over; Arterial Pressure - drug effects; Blood Pressure Monitoring, Ambulatory - instrumentation; Cardiovascular Agents - therapeutic use; Drug Substitution; Female; Heart Failure - diagnosis; Heart Failure - drug therapy; Heart Failure - physiopathology; Humans; Male; Medicare; Patient Readmission; Predictive Value of Tests; Pulmonary Artery - drug effects; Pulmonary Artery - physiopathology; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Telemetry - instrumentation; Time Factors; Transducers, Pressure; Treatment Outcome; United States; Wireless Technology; heart failure; 30-day readmissions; hemodynamic monitoring; disease management; heart failure hospitalization

This study examines the impact of pulmonary artery pressure-guided heart failure (HF) care on 30-day readmissions in Medicare-eligible patients. The CardioMicroelectromechanical system (CardioMEMS) Heart Sensor Allows Monitoring of Pressures to Improve Outcomes in New York Heart Association Class II...